Detalhe da pesquisa
1.
Circulating Tumor Cells Identify Patients with Super-High-Risk Non-Muscle-Invasive Bladder Cancer: Updated Outcome Analysis of a Prospective Single-Center Trial.
Oncologist
; 24(5): 612-616, 2019 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30944184
2.
Letter to the Editor: "Circulating Cell-Free DNA and Circulating Tumor Cells as Prognostic and Predictive Biomarkers in Advanced Non-Small Cell Lung Cancer Patients Treated with First-Line Chemotherapy".
Int J Mol Sci
; 18(6)2017 Jun 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-28629196
3.
Circulating tumor cells isolation: the "post-EpCAM era".
Chin J Cancer Res
; 27(5): 461-70, 2015 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-26543332
4.
Impact of chronic exposure to bevacizumab on EpCAM-based detection of circulating tumor cells.
Chin J Cancer Res
; 27(5): 491-6, 2015 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-26543336
5.
Clinical validity of circulating tumour cells in patients with metastatic breast cancer: a pooled analysis of individual patient data.
Lancet Oncol
; 15(4): 406-14, 2014 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-24636208
6.
Circulating tumor cells detection has independent prognostic impact in high-risk non-muscle invasive bladder cancer.
Int J Cancer
; 135(8): 1978-82, 2014 Oct 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-24599551
7.
Circulating tumor cells in high-risk nonmetastatic colorectal cancer.
Tumour Biol
; 34(5): 2507-9, 2013 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-23539436
8.
Circulating tumour cells lacking cytokeratin in breast cancer: the importance of being mesenchymal.
J Cell Mol Med
; 15(5): 1066-70, 2011 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-21352474
9.
Epithelial-mesenchymal transition and stemness features in circulating tumor cells from breast cancer patients.
Breast Cancer Res Treat
; 130(2): 449-55, 2011 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-21298334
10.
Molecular markers in circulating tumour cells from metastatic colorectal cancer patients.
J Cell Mol Med
; 14(8): 2073-7, 2010 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-20597995
11.
[Role of loco-regional treatments for patients with breast cancer liver metastases]. / Ruolo dei trattamenti loco-regionali nelle pazienti con metastasi epatiche da carcinoma della mammella.
Recenti Prog Med
; 100(9): 424-33, 2009 Sep.
Artigo
em Italiano
| MEDLINE | ID: mdl-19886236
12.
EpCAMlow Circulating Tumor Cells: Gold in the Waste.
Dis Markers
; 2019: 1718920, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31636732
13.
Molecular Characterization of Circulating Tumor Cells to Study Cancer Immunoevasion.
Methods Mol Biol
; 1884: 247-258, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-30465208
14.
Transient Disappearance of RAS Mutant Clones in Plasma: A Counterintuitive Clinical Use of EGFR Inhibitors in RAS Mutant Metastatic Colorectal Cancer.
Cancers (Basel)
; 11(1)2019 Jan 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30621206
15.
Circulating Tumor Cells in Right- and Left-Sided Colorectal Cancer.
Cancers (Basel)
; 11(8)2019 Jul 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-31344798
16.
The clinical use of circulating tumor cells (CTCs) enumeration for staging of metastatic breast cancer (MBC): International expert consensus paper.
Crit Rev Oncol Hematol
; 134: 39-45, 2019 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-30771872
17.
Liquid Biopsy in Rare Cancers: Lessons from Hemangiopericytoma.
Anal Cell Pathol (Amst)
; 2018: 9718585, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-29707475
18.
Circulating tumor cells in young and elderly patients with colorectal cancer: "lupus et agnus".
Aging Clin Exp Res
; 24(6): 722-3, 2012 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-22828412
19.
PD-L1 and epithelial-mesenchymal transition in circulating tumor cells from non-small cell lung cancer patients: A molecular shield to evade immune system?
Oncoimmunology
; 6(12): e1315488, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-29209560
20.
EpCAM-expressing circulating tumor cells in colorectal cancer.
Int J Biol Markers
; 32(4): e415-e420, 2017 Oct 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-28604994